This is a routine administrative filing with no fundamental impact on the company's financials or operations. Traders should note the recent auditor change as a potential point of scrutiny, but this specific amendment does not alter the investment thesis.
Price Chart
Executive Summary
Envoy Medical filed an amended 10-K/A solely to correct a typographical error in Grant Thornton LLP's consent and to include new Section 302 certifications. No financial statement changes or restatements were made. This amendment follows an auditor change disclosed in a recent 8-K.
Key Facts
- The 10-K/A was filed solely to correct a typographical error in Grant Thornton LLP's consent.
- New Section 302 certifications from the CEO and CFO are included in the amendment.
- No changes were made to the financial statements, disclosures, or other content of the original 10-K.
- This amendment follows the company's recent change of auditor from Grant Thornton to EisnerAmper LLP, disclosed in an 8-K filed on March 31, 2026.
Financial Impact
No financial impact. The amendment corrects a non-material administrative error in an auditor consent.
Risk Factors
- The recent auditor change, coupled with this amendment, could signal underlying accounting or financial reporting issues, although none are disclosed here.
- The company remains a small-cap with a history of material weaknesses in internal control over financial reporting, as previously disclosed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001213900-26-043011 |
| Document: ea028599801ex31-3.htm | 0001213900-26-043011 |
| Document: ea028599801ex31-4.htm | 0001213900-26-043011 |
| Document: ea028599801ex23-1.htm | 0001213900-26-043011 |
| Document: 0001213900-26-043011-index-headers.html | 0001213900-26-043011 |
| Document: 0001213900-26-043011-index.html | 0001213900-26-043011 |
| Document: 0001213900-26-043011.txt | 0001213900-26-043011 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 18, 2026 23w ago | 8-K | $0.0475 $0.0325 | ▼ −31.58% | ▼ −32.56% | — |
May 11, 2026 24w ago | 8-K | $0.0475 $0.0475 | · 0.00% | ▲ +0.30% | — |
Apr 17, 2026 27w ago | 3 | $0.0475 $0.0475 | · 0.00% | ▼ −4.20% | — |
Apr 13, 2026 28w ago | 10-K/A | $0.0475 $0.0475 | · 0.00% | ▼ −6.30% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers